GlassScriptPhysician profile
Joe H Johnson
NPI 1326082033
$585.39
in general payments reported to CMS, 2019-2025
13 companies · $190 in 2025
The $190 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $11.85 · 2021: $91.60 · 2022: $124 · 2023: $30.44 · 2024: $26.00 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $246.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $135.87 | 2022-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Shockwave Medical, INC | $76.68 | 2021-2025 | |
| La Jolla Pharmaceutical Company | $64.07 | 2021 | |
| Atricure, INC. | $59.96 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.94 | 2019 | |
| Zimmer Biomet Holdings, INC. | $39.56 | 2019-2020 | |
| Abiomed | $34.81 | 2025 | |
| Silk Road Medical, INC. | $31.80 | 2021-2022 | |
| Biomerieux INC | $26.00 | 2024 | Vidas Nephrocheck |
| Boston Scientific Corporation | $19.51 | 2025 | Watchman Flx |
| Baxter Healthcare | $15.66 | 2025 | Preveleak |
| Pfizer INC. | $13.71 | 2022 | |
| Amneal Pharmaceuticals LLC | $12.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joe Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.